← Leaderboards
David Ko
University Of Southern California
$2,344,909
Attributed
$2,344,909
Total exposure
11
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$2,344,909 · 11
By mechanism
M01$2,344,909 · 11
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Andrea A. Kovacs$11,647,115
- Heinz Josef Lenz$20,123,312
- Jeffrey S Weber$20,866,039
- Don J Diamond$24,317,616
- Jeffrey Y Wong$938,530
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectBrain Disorder ChemotherapyClinical ResearchHuman Therapy EvaluationAnticonvulsantsPartial SeizureDrug Screening /EvaluationPharmacokineticsEpilepsyClinical Trial Phase ICombination ChemotherapyDrug InteractionsQuality Of LifeGeneralized SeizuresTriazoles
Grant awards (49)
GABAPENTIN MONOTHERAPY TRIAL--MULTICENTER STUDY TO DETERMINE EFFICACY$0
M01 · FY2002 · RR
SD 204269 AS ADD ON THERAPY FOR PATIENTS W/ COMPLEX PARTIAL SEIZURES$0
M01 · FY2002 · RR
SB 204269 AS ADD ON THERAPY IN PARTIAL SEIZURE PTS$0
M01 · FY2002 · RR
PATIENTS W/ REFRACTORY PARTIAL SEIZURES$0
M01 · FY2002 · RR
RUFINAMIDE AS ADJUNCTIVE THERAPY IN PATIENTS W/ PARTIAL SEIZURES$0
M01 · FY2002 · RR
534U87 IN PATIENTS W/ EPILEPSY$0
M01 · FY2002 · RR
SB204269 AS ADD ON TX IN REFRACTORY PARTIAL SEIZURES$0
M01 · FY2002 · RR
RUFINAMIDE--EFFICACY AND SAFETY AS ADJUNCTIVE THERAPY FOR PARTIAL SEIZURES$0
M01 · FY2002 · RR
EVALUATION OF SAFETY, TOLERABILITY AND EFFICACY OF ADD ON 534487 IN EPILEPSY$0
M01 · FY2002 · RR
534U87 IN PATIENTS W/ EPILEPSY$155,764
M01 · FY2001 · RR
GABAPENTIN MONOTHERAPY TRIAL--MULTICENTER STUDY TO DETERMINE EFFICACY$155,764
M01 · FY2001 · RR
EVALUATION OF SAFETY, TOLERABILITY AND EFFICACY OF ADD ON 534487 IN EPILEPSY$155,764
M01 · FY2001 · RR
RUFINAMIDE--EFFICACY AND SAFETY AS ADJUNCTIVE THERAPY FOR PARTIAL SEIZURES$155,764
M01 · FY2001 · RR
SB204269 AS ADD ON TX IN REFRACTORY PARTIAL SEIZURES$155,764
M01 · FY2001 · RR
RUFINAMIDE AS ADJUNCTIVE THERAPY IN PATIENTS W/ PARTIAL SEIZURES$155,764
M01 · FY2001 · RR
PATIENTS W/ REFRACTORY PARTIAL SEIZURES$155,764
M01 · FY2001 · RR
SB 204269 AS ADD ON THERAPY IN PARTIAL SEIZURE PTS$155,764
M01 · FY2001 · RR
SD 204269 AS ADD ON THERAPY FOR PATIENTS W/ COMPLEX PARTIAL SEIZURES$155,764
M01 · FY2001 · RR
534U87 IN PATIENTS W/ EPILEPSY$0
M01 · FY2001 · RR
SB 204269 AS ADD ON THERAPY IN PARTIAL SEIZURE PTS$0
M01 · FY2001 · RR
RUFINAMIDE AS ADJUNCTIVE THERAPY IN PATIENTS W/ PARTIAL SEIZURES$0
M01 · FY2001 · RR
EVALUATION OF SAFETY, TOLERABILITY AND EFFICACY OF ADD ON 534487 IN EPILEPSY$0
M01 · FY2001 · RR
RUFINAMIDE--EFFICACY AND SAFETY AS ADJUNCTIVE THERAPY FOR PARTIAL SEIZURES$0
M01 · FY2001 · RR
SB204269 AS ADD ON TX IN REFRACTORY PARTIAL SEIZURES$0
M01 · FY2001 · RR
PATIENTS W/ REFRACTORY PARTIAL SEIZURES$0
M01 · FY2001 · RR
GABAPENTIN MONOTHERAPY TRIAL--MULTICENTER STUDY TO DETERMINE EFFICACY$0
M01 · FY2001 · RR
SD 204269 AS ADD ON THERAPY FOR PATIENTS W/ COMPLEX PARTIAL SEIZURES$0
M01 · FY2001 · RR
EVALUATION OF SAFETY, TOLERABILITY AND EFFICACY OF ADD ON 534487 IN EPILEPSY$155,764
M01 · FY2000 · RR
GABAPENTIN MONOTHERAPY TRIAL--MULTICENTER STUDY TO DETERMINE EFFICACY$155,764
M01 · FY2000 · RR
534U87 IN PATIENTS W/ EPILEPSY$155,764
M01 · FY2000 · RR
SB204269 AS ADD ON TX IN REFRACTORY PARTIAL SEIZURES$155,764
M01 · FY2000 · RR
SD 204269 AS ADD ON THERAPY FOR PATIENTS W/ COMPLEX PARTIAL SEIZURES$35,553
M01 · FY2000 · RR
534U87 IN PATIENTS W/ EPILEPSY$35,553
M01 · FY2000 · RR
SB204269 AS ADD ON TX IN REFRACTORY PARTIAL SEIZURES$35,553
M01 · FY2000 · RR
RUFINAMIDE--EFFICACY AND SAFETY AS ADJUNCTIVE THERAPY FOR PARTIAL SEIZURES$35,553
M01 · FY2000 · RR
EVALUATION OF SAFETY, TOLERABILITY AND EFFICACY OF ADD ON 534487 IN EPILEPSY$35,553
M01 · FY2000 · RR
GABAPENTIN MONOTHERAPY TRIAL--MULTICENTER STUDY TO DETERMINE EFFICACY$35,553
M01 · FY2000 · RR
RUFINAMIDE AS ADJUNCTIVE THERAPY IN PATIENTS W/ PARTIAL SEIZURES$35,553
M01 · FY2000 · RR
PATIENTS W/ REFRACTORY PARTIAL SEIZURES$35,553
M01 · FY2000 · RR
SB 204269 AS ADD ON THERAPY IN PARTIAL SEIZURE PTS$35,553
M01 · FY2000 · RR
RUFINAMIDE ADJUNCT THERAPY IN GENERALIZED TONIC-CLONIC S$0
M01 · FY2000 · RR
RUFINAMIDE ADJUNCT THERAPY IN GENERALIZED TONIC-CLONIC S$0
M01 · FY2000 · RR
RUFINAMIDE AS ADJUNCTIVE THERAPY IN PATIENTS W/ PARTIAL SEIZURES$0
M01 · FY2000 · RR
SD 204269 AS ADD ON THERAPY FOR PATIENTS W/ COMPLEX PARTIAL SEIZURES$0
M01 · FY2000 · RR
RUFINAMIDE--EFFICACY AND SAFETY AS ADJUNCTIVE THERAPY FOR PARTIAL SEIZURES$0
M01 · FY2000 · RR
RUFINAMIDE ADJUNCT THERAPY IN PRIMARY GENERALIZED SEIZUR$0
M01 · FY2000 · RR
PATIENTS W/ REFRACTORY PARTIAL SEIZURES$0
M01 · FY2000 · RR
RUFINAMIDE ADJUNCT THERAPY IN PRIMARY GENERALIZED SEIZUR$0
M01 · FY2000 · RR
SB 204269 AS ADD ON THERAPY IN PARTIAL SEIZURE PTS$0
M01 · FY2000 · RR